Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 863, pseudogene (RNU6-863P) is a non-coding RNA classified as a pseudogene of the U6 small nuclear RNA. U6 snRNA is a highly conserved component of the spliceosome and is crucial for pre-mRNA splicing in eukaryotes, but RNU6-863P itself is a pseudogene, meaning it is a DNA sequence similar to the functional U6 gene but does not generally produce a functional product[3][2]. Pseudogenes like RNU6-863P may be transcribed, but they lack identified physiological or pathophysiological function and are not considered canonical therapeutic targets[2]. There is no evidence that RNU6-863P plays a direct role in disease, serves as a biomarker, or is targeted by any drugs; its main relevance is as an annotated non-functioning remnant of a functional snRNA gene[2][3]. Key clarification: - RNU6-863P is a pseudogene, not an active snRNA, protein, or receptor. - It is not a therapeutic target and does not have a direct biological or pharmacological function[2][3]. - Any listings or references to this pseudogene as a therapeutic target are incorrect or arise from annotation artifacts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 863, pseudogene (RNU6-863P).